Opus Genetics's total assets for Q3 2025 were $36.12M, a decrease of -6.58% from the previous quarter. IRD total liabilities were $30.16M for the fiscal quarter, a 42.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.